Investment Reports

Get to know the rationale behind great ideas for you to make sound long term investment decisions.

Refine Search


Date

215/215 Reports

  • Result Update:Birla Corpn.
    Result Update:Birla Corpn.

    25 Jan 2021

    Stocks covered (1)

    We recommend to BUY with a target price of Rs.800/share, valuing the company at 5.5x of its FY22E EV/Ebitda.
  • Result Update:Zensar Tech.
    Result Update:Zensar Tech.

    25 Jan 2021

    Stocks covered (1)

    We recommend HOLD and assign 12x P/E multiple to its FY23E earnings of Rs. 22.7 per share which gives a TP of Rs. 263 per share, an upside of 9%.
  • Result Update:Biocon
    Result Update:Biocon

    25 Jan 2021

    Stocks covered (1)

    We recommend “BUY’ with target price of INR 435 (35x FY22E earnings).
  • Result Update:SBI Life Insuran
    Result Update:SBI Life Insuran

    25 Jan 2021

    Stocks covered (1)

    We maintain a Buy with a target price of Rs 1076 (2.6xFY23E EV).
  • Pick of the Week:25 JAN 2021
    Pick of the Week:25 JAN 2021

    25 Jan 2021

    Stocks covered (1)

    We recommend a BUY with a target price of Rs 1,495.
  • Result Update:SBI Cards
    Result Update:SBI Cards

    22 Jan 2021

    Stocks covered (1)

    We revise our rating from HOLD to BUY. We value the stock at 38x FY23E EPS and arrive at a price target to Rs. 1100.
  • Result Update:Bajaj Auto
    Result Update:Bajaj Auto

    22 Jan 2021

    Stocks covered (1)

    We retain BUY rating with revised TP of Rs. 4,150 (Rs. 3,500 earlier) (which includes Rs 150/share for company’s stake in KTM) as we value the stock at 17x (16x earlier) its FY23E EPS.
  • Result Update:Asian Paints
    Result Update:Asian Paints

    22 Jan 2021

    Stocks covered (1)

    We downgrade the stock to HOLD from BUY earlier as we await better entry points and get constructive again. Our revised TP is Rs. 2,664 (Rs. 2,300 earlier) as we value the stock at 55x its FY23E EPS. Key risks to our estimates
  • Result Update:Cyient
    Result Update:Cyient

    22 Jan 2021

    Stocks covered (1)

    We recommend BUY and assign 14x P/E multiple to its FY23E earnings of Rs. 44.5 per share which gives a TP of Rs. 623 per share, an upside of 23%.